ES2139227T3 - Concentrado de fibrinogeno obtenido de plasma sanguineo, procedimiento e instalacion para su preparacion. - Google Patents

Concentrado de fibrinogeno obtenido de plasma sanguineo, procedimiento e instalacion para su preparacion.

Info

Publication number
ES2139227T3
ES2139227T3 ES95927599T ES95927599T ES2139227T3 ES 2139227 T3 ES2139227 T3 ES 2139227T3 ES 95927599 T ES95927599 T ES 95927599T ES 95927599 T ES95927599 T ES 95927599T ES 2139227 T3 ES2139227 T3 ES 2139227T3
Authority
ES
Spain
Prior art keywords
procedure
installation
preparation
blood plasma
fibrinogen concentrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95927599T
Other languages
English (en)
Other versions
ES2139227T5 (es
Inventor
Ruth Laub
Wael Luc De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CAF DCF DEPARTEMENT CENTRAL DE
Original Assignee
CAF DCF DEPARTEMENT CENTRAL DE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8218658&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2139227(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by CAF DCF DEPARTEMENT CENTRAL DE filed Critical CAF DCF DEPARTEMENT CENTRAL DE
Publication of ES2139227T3 publication Critical patent/ES2139227T3/es
Application granted granted Critical
Publication of ES2139227T5 publication Critical patent/ES2139227T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0042—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Processing Of Meat And Fish (AREA)
  • External Artificial Organs (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN CONCENTRADO DE FIBRINOGENO CARACTERIZADO PORQUE ESTA DESPROVISTO DE CONTAMINANTES VIRALES Y PORQUE SU PUREZA ES SUPERIOR A 95%. LA PRESENTE INVENCION SE REFIERE TAMBIEN AL PROCEDIMIENTO DE OBTENCION DE DICHO CONCENTRADO DE FIBRINOGENO.
ES95927599T 1994-07-14 1995-07-14 Concentrado de fibrinógeno obtenido de plasma sanguíneo, procedimiento e instalación para su preparación. Expired - Lifetime ES2139227T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94870121 1994-07-14
EP94870121 1994-07-14

Publications (2)

Publication Number Publication Date
ES2139227T3 true ES2139227T3 (es) 2000-02-01
ES2139227T5 ES2139227T5 (es) 2011-05-04

Family

ID=8218658

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95927599T Expired - Lifetime ES2139227T5 (es) 1994-07-14 1995-07-14 Concentrado de fibrinógeno obtenido de plasma sanguíneo, procedimiento e instalación para su preparación.

Country Status (9)

Country Link
US (1) US5834420A (es)
EP (1) EP0771324B2 (es)
JP (1) JP4211894B2 (es)
AT (1) ATE184884T1 (es)
CA (1) CA2195127C (es)
DE (1) DE69512416T3 (es)
ES (1) ES2139227T5 (es)
IL (1) IL122665A (es)
WO (1) WO1996002571A1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69512416T3 (de) * 1994-07-14 2011-12-15 Croix Rouge De Belgique Fibrinogenkonzentrate aus blutplasma, verfahren und anlage für ihre herstellung
EP1842561A1 (fr) * 1995-07-14 2007-10-10 CAF - DCF cvba - scrl Procédé et installation d'inactivation UV de virus dans des produits sanguins
EP1115742B1 (en) * 1998-09-24 2006-03-29 Pharming Intellectual Property BV Purification of fibrinogen from milk by use of cation exchange chromatography
AU6104799A (en) 1998-09-24 2000-04-10 Ppl Therapeutics (Scotland) Limited Purification of fibrinogen from fluids by precipitation and hydrophoic chromatography
FR2785206B1 (fr) * 1998-10-14 2001-01-19 Fond Jean Dausset Ceph Dispositif de centrifugation pour automate de laboratoire
US6946140B1 (en) * 1999-02-09 2005-09-20 The Research Foundation Of State University Of New York Methods and compositions for enhancing fibroblast migration
KR20020063597A (ko) * 1999-12-20 2002-08-03 미츠비시 웰파마 가부시키가이샤 다공성막으로 처리되어 바이러스가 제거된 혈장 단백질조성물 및 그 제조 방법
ES2327208T3 (es) * 1999-12-23 2009-10-27 Csl Limited Separacion de fibrinogeno de proteasas de plasma.
US20030086817A1 (en) * 2001-11-06 2003-05-08 Horton Isaac B. Blood purification system
ES2318145T3 (es) * 2002-02-19 2009-05-01 Resolution Chemicals Limited Esterilizacion de esteroides por medio de disolventes.
US8986607B2 (en) 2003-02-27 2015-03-24 Baxter International Inc. Method for the validatable inactivation of pathogens in a biological fluid by irradiation
US20050124038A1 (en) * 2003-07-14 2005-06-09 Pharmacia Corporation Transfection of cartilage and matrices thereof in vitro
EP2335650B1 (en) 2003-12-11 2012-10-03 Isto Technologies Inc. Particulate cartilage system
WO2005081870A2 (en) * 2004-02-20 2005-09-09 Isto Technologies, Inc. Intervertebral disc repair, methods and devices therefor
DE102004009400A1 (de) 2004-02-24 2005-09-08 Zlb Behring Gmbh Fibrinogen Reinigung
AU2005265960B8 (en) * 2004-06-29 2012-01-12 Reliance Life Sciences Pvt Ltd Process for improvement of virus-safe biological fluids
FR2887883B1 (fr) * 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
BRPI0909724A2 (pt) * 2008-03-28 2017-06-13 Res Foundation For Medical Devices método de inativação viral de fluidos biológicos por tratamento com solvente/detergente.
EP2619225B1 (en) 2010-09-20 2016-06-15 Octapharma AG Process for production of fibrinogen
US20140287044A1 (en) * 2011-03-04 2014-09-25 Rare Antibody Antigen Supply, Inc. Fibrin sealant (fibringluraas) consisting of a kit of lyophilized or frozen high concentrate fribinogen
US10112972B2 (en) 2012-03-13 2018-10-30 Octapharma Ag Process for production of fibrinogen and fibrinogen produced thereby
CH706420A1 (fr) * 2012-04-19 2013-10-31 Valerie Soulie Procédé d'inactivation virale d'un fluide biologique, dispositif et récipient pour la mise en œuvre d'un tel procédé.
US20140154233A1 (en) * 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
US10188965B2 (en) 2012-12-05 2019-01-29 Csl Behring Gmbh Hydrophobic charge induction chromatographic depletion of a protein from a solution
IL231230A0 (en) 2014-02-27 2014-08-31 Omrix Biopharmaceuticals Ltd Fibrinogen preparation
US9932388B2 (en) 2014-11-13 2018-04-03 Hemarus Therapeutics Limited Chromatographic process for producing high purity fibrinogen and thrombin
US20230022328A1 (en) * 2019-12-10 2023-01-26 Biotest Ag Method for Manufacturing a Fibrinogen Preparation
CN111518197B (zh) * 2020-03-30 2024-01-05 哈尔滨派斯菲科生物制药有限公司 一种纤维蛋白原的生产方法
JP7645133B2 (ja) * 2021-06-04 2025-03-13 Ｋｍバイオロジクス株式会社 血液凝固第ｘｉｉｉ因子を含むフィブリノゲンの製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5598196A (en) * 1979-01-16 1980-07-25 Meito Sangyo Kk Fractionation of fibrinogen or its constituents and their use
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
US4481189A (en) † 1982-04-14 1984-11-06 New York Blood Center Inc. Process for preparing sterilized plasma and plasma derivatives
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
GB8505882D0 (en) * 1985-03-07 1985-04-11 Central Blood Lab Authority Purification of blood coagulation factor viii
DE3734923C1 (de) † 1987-10-15 1989-01-26 Biotest Pharma Gmbh Verfahren zur Herstellung einer sterilen Plasmaproteinloesung,die Fibrinogen und den Gerinnungsfaktor XIII enthaelt
FR2632309B1 (fr) † 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
CA2007545A1 (en) † 1989-01-13 1990-07-13 Yahiro Uemura Production method for protein-containing composition
EP0602173B1 (en) * 1991-09-05 1999-05-26 Baxter International Inc. Topical fibrinogen complex
FR2686883B1 (fr) * 1992-02-04 1994-05-13 Aquitaine Develop Transf Sanguin Procede de fabrication de fibrinogene de tres haute purete, fibrinogene de tres haute purete obtenu ainsi qu'une composition pharmaceutique le contenant.
DE69512416T3 (de) * 1994-07-14 2011-12-15 Croix Rouge De Belgique Fibrinogenkonzentrate aus blutplasma, verfahren und anlage für ihre herstellung

Also Published As

Publication number Publication date
CA2195127C (en) 2007-06-19
EP0771324A1 (fr) 1997-05-07
CA2195127A1 (en) 1996-02-01
EP0771324B2 (fr) 2011-02-09
IL122665A (en) 2001-08-26
DE69512416T3 (de) 2011-12-15
US5834420A (en) 1998-11-10
DE69512416D1 (de) 1999-10-28
ATE184884T1 (de) 1999-10-15
JPH10506607A (ja) 1998-06-30
IL122665A0 (en) 1998-08-16
JP4211894B2 (ja) 2009-01-21
WO1996002571A1 (fr) 1996-02-01
DE69512416T2 (de) 2000-02-17
ES2139227T5 (es) 2011-05-04
EP0771324B1 (fr) 1999-09-22

Similar Documents

Publication Publication Date Title
HN1997000146A (es) Derivados de pirimidina biciclica condensada
CA2195127A1 (en) Concentrate of fibrinogene obtained from blood plasma, process and plant for its preparation
HN1997000072A (es) Procedimiento para la preparacion de sildenafil
ES2164060T3 (es) Concentrado de enzima purificada y metodo de preparacion.
HN1998000020A (es) Derivados de acido arilsulfonilhidroxamico.
ATE227567T1 (de) Präparate zur hemmung der durch osteoklasten vermittelten knochenresorption
DK0994108T3 (da) Fremgangsmåde til fremstilling af 2-hydroxybenzamidderivater
BR9502522A (pt) Composiçao concentrada em suspensao
EP0924199A4 (es)
FR2599752B1 (fr) Variants de l'alpha1- antitrypsine utiles notamment comme inhibiteurs de la kallikreine
SE9300595D0 (sv) Mellanprodukter foer framstaellning av antihyperkolesterolemiska medel
ES2055503T3 (es) Diimida de silicio y procedimiento para su fabricacion, y para la fabricacion de nitruro de silicio generado a partir de la misma.
FI970753L (fi) Menetelmä 4-sulfofenyyli/(1-oksialkanoyyli)amino/alkanoaatin puhdistettujen alkalimetallisuolojen valmistamiseksi välituotteita eristämättä
BR9408223A (pt) Composto derivado de 4-benzoilisoxazol processo de preparação composição herbicida método de controle herbicida e compostos intermediarios
DK0536197T3 (da) Ren, krystallinsk form af rifapentine
PT1075480E (pt) Purificacao de carboxaldeido
IL120371A (en) Process for the preparation of unsymmetrical 4,6-bis (aryloxy) pyrimidine compounds and novel intermediates thereof
BR9810481A (pt) Processo para preparação de 1h-indol-3-glioxamidas 4-substituìdas.
ZA988508B (en) Novel stereoselective processes for the preparation of gabapentin and anologues thereof
PT837677E (pt) Derivados hexa-hidroxibifenilo bromados
GR3034406T3 (en) Intermediates for the preparation of 2-imidazoline-5-ones
FR2708603B1 (fr) Procédé de préparation d'hydroperoxyde de cumène.
BR9909697A (pt) Processo para preparação de 1h-indol-3-glioxamidas 4-substituìdas
BR9809439A (pt) Processos para preparação de benzotiofenos
DE50115830D1 (de) Lagerungselement zur spannungsfreien Befestigung von Platten an Tragkonstruktionen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 771324

Country of ref document: ES